The North Carolina Biotechnology Center awarded 71 grants and loans totaling $2,757,090 to universities, bioscience companies and non-profit organizations in the third quarter of its fiscal year.The awards, made in January, February and March, will support life science research, technology commercialization and entrepreneurship throughout North Carolina. The funding will also help universities and companies attract follow-on funding from other sources.
The North Carolina Biotechnology Center awarded 18 grants and loans totaling $1,755,181 to universities, bioscience companies and nonprofit organizations in the third quarter of its fiscal year.
Venture Day 2022 Highlights Early-stage Life-science Companies in the Triangle – Duke OTC duke.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duke.edu Daily Mail and Mail on Sunday newspapers.
by Barry Teater, NCBiotech Writer May 13, 2021 .
RESEARCH TRIANGLE PARK The North Carolina Biotechnology Center awarded 48 grants and loans totaling nearly $1.8 million to universities, bioscience companies and other entities in the third quarter of its fiscal year.
The awards, made in January, February and March, support life sciences research, technology commercialization and entrepreneurship throughout North Carolina. The funding also helps universities and companies attract follow-on funding from other sources.
Company loans
Three bioscience companies received Small Business Research Loans totaling $550,000 to advance their research, product development and commercial viability.
Alacrity Medical Innovations of Chapel Hill received $100,000 to complete prototype development and prepare for an Investigational New Drug (IND) filing with the U.S. Food and Drug Administration for a disposable, drug-device combination product that treats mild to moderate bleeding in patients